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Abstract
Background: Consensus guidelines have recommended that decision aids include a process for helping patients
clarify their values. We sought to examine the theoretical and empirical evidence related to the use of values
clarification methods in patient decision aids.
Methods: Building on the International Patient Decision Aid Standards (IPDAS) Collaboration’s 2005 review of
values clarification methods in decision aids, we convened a multi-disciplinary expert group to examine key
definitions, decision-making process theories, and empirical evidence about the effects of values clarification
methods in decision aids. To summarize the current state of theory and evidence about the role of values
clarification methods in decision aids, we undertook a process of evidence review and summary.
Results: Values clarification methods (VCMs) are best defined as methods to help patients think about the
desirability of options or attributes of options within a specific decision context, in order to identify which option
he/she prefers. Several decision making process theories were identified that can inform the design of values
clarification methods, but no single “best” practice for how such methods should be constructed was determined.
Our evidence review found that existing VCMs were used for a variety of different decisions, rarely referenced
underlying theory for their design, but generally were well described in regard to their development process.
Listing the pros and cons of a decision was the most common method used. The 13 trials that compared decision
support with or without VCMs reached mixed results: some found that VCMs improved some decision-making
processes, while others found no effect.
Conclusions: Values clarification methods may improve decision-making processes and potentially more distal
outcomes. However, the small number of evaluations of VCMs and, where evaluations exist, the heterogeneity in
outcome measures makes it difficult to determine their overall effectiveness or the specific characteristics that
increase effectiveness.
Background
Consensus recommendations have indicated that deci-
sion aids should include some method to help patientsa
consider how they value key aspects of the decision with
which they are faced [1]. These recommendations are
based on the belief that, by clarifying individuals’ values,
the medical treatments that people actually receive will
be more reflective of their personal preferences and treat-
ment goals [2,3]. Whether such recommendations have
strong theoretical and empirical justification remains
controversial [4,5]. In fact, there is debate about whether
patients’ participation in values clarification actually
improves the quality of their decision making [2].
The purpose of this paper is to summarize the current
state of theory and evidence with respect to the role of
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values clarification methods (VCMs) in patient decision
aids. Through this overview, we hope to clarify when
and how values clarification methods are used within
decision aids, and to determine what further research
needs to be done to improve the design and use of
values clarification methods.
To better understand the state of the science pertaining
to the inclusion of values clarification methods within
decision aids, we undertook a process of evidence review
and summary, described in greater detail below. Briefly, an
international, multi-disciplinary committee of researchers
in the field conducted a series of meetings over 18 months.
Two sub-groups reviewed the relevant chapter in the
International Patient Decision Aid Standards (IPDAS)
Collaboration’s 2005 Background Document [6]; each
sub-group was charged with one of two tasks. The theory
and definitions sub-group was charged with developing
an updated set of definitions and a summary of relevant
theory that describes decision-making processes and their
implications for values clarification [7]. The evidence
sub-group was charged with conducting a systematic
review of VCMs used and tested within decision aids [8].
Work from the two sub-committees was combined and
edited to produce this report.
An updated definition of values clarification
methods
The relevant chapter in the IPDAS Collaboration’s 2005
Background Document uses the term “values clarifi-
cation exercises”, and defines these as “[Exercises to]
help patients to clarify and communicate the personal
value of options, in order to improve the match between
what is personally most desirable and which option is
actually selected.” [6]
In this update, in order to improve clarity, we chose to
set aside the term “exercises” and use the term “values
clarification methods”. We then defined values clarifica-
tion methods (VCMs) as strategies that are intended to
help patients evaluate the desirability of options or attri-
butes of options within a specific decision context, in
order to identify which option he/she prefers.
Thus, our updated definition differs from the 2005
definition in two major ways. First, it focuses not only
on the attributes of options (e.g., the probability of cure,
the impact on bladder functioning), but also on the
options as whole entities (e.g., the holistic comparison
of surgery to radiotherapy), as well as on the decision
context (e.g., the option that the doctor recommends,
the option that my partner/children prefer). We use this
broad definition because any of the above aspects of the
situation—attributes, entities, context—may be relevant
during the process of clarifying which option an indivi-
dual prefers. Secondly, our updated definition does not
include the communication of values to others, since
this is considered to be a different aspect of the design
of decision support interventions [2,3]).
Although values clarification methods can be either
implicit and non-interactive (e.g., the patient thinks about
what’s important to his decision) or explicit and interactive
(e.g., the patient sets a rating scale for each attribute
to reflect the importance of each to his decision) [6,9],
this paper is focused on the more studied and better
understood explicit values clarification methods.
Theoretical rationale for evaluating patient
decision aids on this quality dimension
Original theoretical rationale
In the relevant chapter in the IPDAS Collaboration’s
2005 Background Document [6], different types of
VCMs were described, including the mechanisms by
which these methods may help patients to clarify their
values. These mechanisms included:
1. Considering detailed information about the options
and their outcomes, which helps to promote under-
standing of what it means to undergo the procedures
involved and to face the physical, emotional, and social
consequences;
2. Considering how others value features of options
and whether the participant is similar to others (social
matching); and
3. Rating or ranking features of options or trading off
features of options, which may give insight into one’s
personal values and/or the tradeoffs underlying the
choice for one versus other options.
Note that these mechanisms did not refer to underlying
theories.
An updated theoretical rationale
We argue that VCMs are deemed to be helpful to
patients because they provide assistance with particular
decision processes. Decision-making process theories
may provide useful guidance for us to gain better under-
standing about why or how values clarification methods
affect decision processes. The theories presented in
Additional file 1 Table S1a were selected because they
specify particular decision processes, and hence provide
the basis from which the subset of processes that VCMs
may be able to assist were derived. These theories are
described in greater detail in Additional file 2 Appendix
1. (Because some theories, such as Expected Utility Theory
(EUT) and theories of behavioral change (e.g., Trans-
theoretical Model), do not specify particular decision
processes, they cannot guide identification of the
processes that VCMs might be able to help.)
Relevant theory-informed processes underlying values
clarification
Several decision-making processes are relevant to values
clarification. A specific VCM need not aim to address
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all decision-making processes, but should aim to facili-
tate, explicitly or implicitly, at least one or more of the
following decision-making processes:
1. Identifying options, which can include either the
narrowing down of options, or the generation of options
that were not offered at the outset.
2. Identifying attributes of the situation and/or the
options which ultimately affect the patient’s preference
in a specific decision context.
3. Reasoning about options or attributes of options.
4. Integrating attributes of options using either com-
pensatory or both compensatory and non-compensatory
decision rules. (A compensatory decision rule allows the
impact of an option’s attributes to be averaged so that a
poor score on one attribute can be offset by a high score
on a second attribute. A non-compensatory decision rule
is a strategy that avoids tradeoffs; for example, a strategy
in which the decision maker decides on a threshold that
a particular attribute must meet for options to remain
under consideration. Each option is evaluated on its own
without consideration of other options)
5. Making holistic comparisons.
6. Helping decision makers retrieve relevant values
from long-term memory.
Additional file 1 Table S1b provides examples of these
decision-making processes, in the context of decision
making about prostate cancer treatment.
Empirical evidence: rationale, recent studies,
evaluation
Below, the first sub-section presents a basic empirical
rationale for evaluating the quality of a patient decision
aid in terms of the method(s) it uses to foster values
clarification. Then we outline the results of our updated
review of the empirical evidence about the inclusion of
VCMs in patient decision aids in two further sub-sections:
the recent studies that have included VCMs in patient
decision aids; and the evaluation of VCMs.
An empirical rationale for evaluating patient decision
aids on this quality dimension
Considerable evidence suggests that individuals facing
new and complex decisions often do not have stable or
clear preferences [10,11]. For example, Feldman-Stewart
et al. showed that almost all early-stage prostate cancer
patients who made use of a decision aid made changes
from pre-test to post-test (i.e., within several hours) to
the attributes that they identified as affecting their decision
[12]. Importantly, these were patients who had already
talked to their urologist and their radiation oncologist, and
may have become clearer about what was important to
them during those discussions. Based on the empirical
evidence suggesting that patients may have unclear or
unstable preferences, we argue that it continues to be
important, when evaluating the quality of patient decision
aids, to take into consideration the methods (if any) that
are used to foster values clarification.
In the relevant chapter in the IPDAS Collaboration’s
2005 Background Document [6], the authors found 19
studies that employed VCMs [6]. They noted that most
(72%) offered examples of how the values of other
patients who had to make this decision led them to make
different choices, and almost half (42%) incorporated
some explicit means of measuring one’s values (e.g.,
rating, trade-offs, balance scales). However, few studies
had examined the specific effects of including a VCM in
a patient decision aid. Given the paucity of early evidence
about the effects of VCMs in patient decision aids, we
argue that our updated review of more recent relevant
studies is timely.
Recent studies that have included VCMs within
decision aids
Witteman et al. conducted a rigorous systematic review
of VCMs, and identified 61 VCMs that were used within
a decision aid through June 2011 [8]. In their review,
Witteman and colleagues examined a large number of
the characteristics of these VCMs and of the decision
aids in which they were embedded. We present a sub-
set of these data here. Our goal was to describe the
state of the science of studies that include VCMs. Thus,
the factors we ultimately decided to highlight were
based on the following principles: 1) the characteristics
of the studies in which the VCMs were presented (e.g.,
the decision context), 2) the characteristics influencing
how a particular VCM was originally designed (e.g., the
development process), and 3) the characteristics of the
VCMs themselves (e.g., the type of VCM utilized). Our
review is therefore limited to “higher level” characteristics
of the VCMs and the studies in which they were
included. Witteman and colleagues’ full paper provides
additional details on these and other components. The
key features of existing VCMs are described in Additional
file 3 Table S2 and are briefly summarized below.
Characteristics of studies that included VCMs
What was the decision context? Types of decisions
were catalogued by the decision context: whether the
decision addressed 1) treatment, 2) prevention, 3)
screening (other than genetic screening), or 4) genetic
testing. Of the 61 VCMs, 46% focused on treatment
decisions, 25% on prevention decisions, 33% on screen-
ing behaviors (not including genetic testing), and 10%
on decisions about genetic testing. Three VCMs
addressed two of the above decision contexts, one
addressed three contexts, and one addressed all four.
What medium was the VCM designed for? The VCMs
reviewed were designed to be completed on paper
(49%), using a computer (38%), or verbally (15%); two
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VCMs used two different media, thus numbers do not
sum to 100%.
Where was the VCM located within the larger decision
support tool? Values clarification methods can be placed
before or after the presentation of the relevant informa-
tion needed to make a decision. The vast majority (85%)
of the VCMs were presented after the information
section.
Were decision intentions measured? In over a third of
the studies (38%), participants were not asked any ques-
tions about their decisions (intentions or actual). In 34%
of the studies, participants were asked which way they
were leaning, while in 28% they were asked to report
their actual decision.
Characteristics influencing the design of the VCM
What theory, framework, model, or mechanism
underlie the development of the VCM? Twenty-five
percent of the studies (15/61) did not report any theory,
framework, model, or mechanism. Among the remaining
46 studies with any underlying structure (either apparent
or reported), 39 (i.e., 64% out of the 61 total) had a theory,
framework, model, or mechanism underlying the overall
decision aid, which was not necessarily relevant to the
VCM. Twenty-two studies out of the 46 (i.e., 36% out of
the 61 total) had a theory, framework, model, or mechan-
ism specifically underlying the VCM. It should be noted
that some studies reported theory for both the VCM and
the overarching decision aid; thus the numbers presented
in Additional file 3 Table S2 do not sum to 100%. The
most common theory was expected utility theory (18%),
even though this theory makes no predictions about how
VCMs can improve the process of medical decision
making.
Was the development process described and what was
the development process? Most of the articles (74%)
described, in some way, the development process of either
the decision aid or the VCM. Of those that did include
details, the development process used included literature
reviews (42%), expert reviews (51%), and/or testing (80%).
Individuals involved in the development process included
health professionals (53%), academic experts (31%), and
patients who have previously faced the decision (38%).
Because many of the articles used multiple processes and
participants in their development of the tool, the numbers
in Additional file 3 Table S2 do not sum to 100%. Less
than half (39%) of the VCMs in decision aids were devel-
oped and evaluated using established guidelines, most
often the IPDAS standards (28% of the VCMs).
Characteristics of the VCM
What type of VCM was used? Ten categories of VCMs
were utilized. The most common types were considering
the pros versus cons (46%), utility assessment with or
without decision analysis (18%), prioritization (11%), and
rating scales (11%) (see Additional file 3 Table S2).
Were the results of the VCM presented to participants?
Thirty-nine percent of the studies explicitly showed
participants the result of the VCM, most of which
occurred before the patient was asked to indicate their
decision. Fifty-seven percent did not explicitly provide
feedback to participants.
Evaluation of the VCMs
The committee reviewed thirteen studies that compared
the effects of decision support with and without VCMs
and one study that compared two different approaches
to using a single VCM (see Additional file 4 Table S3).
The selected articles were derived from the Witteman
review [8]. Only studies that included VCMs within the
context of a decision aid are included here. The identi-
fied studies examined a range of health conditions, with
cancer-related topics being the most common (6/13).
Sample sizes ranged from small (5 of 13 studies with
less than 100 participants) to moderately large (4 studies
with 400 or more participants). Several different types of
VCMs were employed. Available studies examined a
wide range of outcomes, and no outcomes were assessed
in the same manner across all or most studies. Reported
outcomes included likeability of the VCM, knowledge,
decision-making processes, decisional conflict, uncer-
tainty, satisfaction, decision preference, treatment intent,
actual health behaviors, regret and, in a few cases, health
outcomes or cost.
The effects of the VCMs were mixed: decision processes
were improved in 5 of 8 studies, but other outcomes were
not measured frequently enough to reach conclusions
about whether the VCMs had mainly positive or mainly
neutral effects; no trials, however, suggested that VCMs
led to worse outcomes (see Additional file 5 Table S4).
Discussion: emerging issues and research areas
Although the number of studies of VCMs and decision
aids is growing rapidly, our review highlights that many
questions about the effects of VCMs remain unanswered.
We outline several such issues here.
Proposed theories
Above, we discussed a number of decision-making process
theories without intending to establish agreement about a
single theory, or a set of theories, that should be viewed
as most promising in providing guidance for the design
and evaluation of VCMs. More research is needed across
contexts (e.g., healthcare settings) and cultures to better
understand how VCMs might be designed to contribute
to decision making. Such understanding requires testing
VCMs based on specific theory, including theory-based
predictions of anticipated effects on outcomes and consid-
eration of how such VCMs might contribute to effective
decision making.
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Intuitive processes
There is a debate currently about the value of intuitive
processes in decision making. Intuitive processing is
typically characterized by a lack of overt cognitive effort
and the implicit integration of available information. In
contrast, deliberative processing generally involves
effortful, conscious and analytical thought [13]. Impor-
tantly, intuitive and deliberative processes should not be
conflated with implicit versus explicit VCMs. Although
explicit VCMs are often effortful, and thereby require
deliberative thought, an implicit VCM may also be quite
effortful and activate analytical thought processes.
From research outside of health care [14], deliberative
reasoning about pros and cons may cause people to
focus on attributes that are obvious, accessible, and easy
to articulate, and these attributes may not be the ones
that are actually the most important factors in the deci-
sion. Therefore, in contexts outside of health care, there
is evidence to suggest that deliberation can cause people
to ignore attributes that lead to long-term satisfaction.
There is also evidence to suggest that intuitions can
accurately reflect the integration of a large amount of
information [13,15] However, the decisions that have
been studied in the psychology literature are typically
hypothetical and/or familiar decisions [cf. [16]]. There is
little research yet to assess to what extent these results
are expected to hold for users facing new, complex, pre-
ference-sensitive health related decisions. Until more
research is available on the value of intuitive processes in
such decision contexts, it is unclear to what extent a
VCM that encourages intuitive processing of options
would be effective to help people sort out what is most
important to them. Additionally, the psychological litera-
ture described above suggests that the deliberation that is
encouraged by VCMs may actually be counterproductive.
Significantly more research is needed to determine
whether VCMs are helpful, harmful, or neutral in terms
of promoting good decision processes.
An increasing number of theories of decision making
assume both intuitive and deliberative decision-making
processes. Importantly, intuition and deliberation are
not mutually exclusive, and extensive research shows
both types of processes are used.
How VCMs fit with patient-provider shared decision
making
Researchers and practitioners need to better understand
how values clarification relates to shared decision mak-
ing (SDM). Is values clarification a pre-requisite to, or
an element of, SDM? Does it improve SDM? Through
the process of SDM, health care providers may elicit
patients’ and their families’ values. Patients and their
families may not necessarily be clear about their own
values before the conversation with the health care team
and may, on the contrary, be guided to become clear in
the SDM process. Whether a VCM should precede the
consultation with the health care provider, be used
within the consultation, follow that conversation, or
even used at all requires further study.
When VCMs are used could affect how they influence
patient-provider communication. VCMs could precede
the consultation, be completed during the consultation,
or after the consultation. VCMs that were conducted
prior to the consultation could be useful in that patients
could have a better sense of their values and preferences
and be better able to state their treatment preferences
and goals for treatment. On the other hand, if the VCM
is completed during the consultation the process itself,
this could facilitate, and hopefully improve, shared deci-
sion making. VCMs conducted after the consultation
may be less beneficial (especially if the patient does not
see the physician following the VCM), as the patient
would not have an opportunity to share potentially new
information about their preferences and values.
Use of VCMs with surrogate decision makers
More evidence is needed to determine whether VCMs
would also be helpful for others involved in the decision-
making processes. That is, what is the impact of VCMs
designed to support the clarification of the values of
those who influence the treatment decision and who are
affected by the outcome of the decision (e.g., caregivers
or partners of patients)? Similarly, are VCMs helpful for
surrogate decision makers who are trying to make deci-
sions on behalf of the patient and, in doing so, are trying
to construct that patient’s values from their knowledge of
the patient?
Use of VCMs to reach a decision involving multiple
people
More research is needed to examine how VCMs can be
used to help multiple people (such as health care provi-
ders and family members) who are working together to
support the patient’s decision. Specifically, little is
known about how VCMs can help clarify the values that
influence the advice of others to patients, as well as how
VCMs could be used in a process leading to consensus
about the choice (when consensus does not violate the
autonomy of the patient).
The role of distal outcomes
Attempts to develop measures of the effectiveness of
VCMs have often focused on decision-making processes,
likely because such processes are directly affected by the
VCMs. More distal outcomes – including effects on
regret, satisfaction, behaviors, actual decisions, and mea-
sures of health – may also be important measures of the
effect of VCMs, but are often affected by many other
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factors. How best to incorporate these more distal
outcomes into the evaluation of VCMs warrants further
study.
Implicit versus explicit VCMs
More research is needed to ascertain the “active ingredi-
ents” of a VCM, that is, the components that make
independent contributions to facilitating good decision-
making processes that the VCM aims to facilitate. In
particular, more research is needed to clarify (a) what is
required for implicit values clarification, and (b) if the
use of strategies to encourage implicit values clarifica-
tion is helpful, compared with explicit VCMs and also
compared with no VCMs.
How to handle more than two options
More research is needed to examine whether, in the
case of multiple options, it is necessary to present all of
the options, and whether multiple options should be
considered simultaneously or in series. For example, it
may be more helpful to identify attributes and then pre-
sent only the options that match the attributes the indi-
vidual who faces the decision considers most important.
Or rather, it may be more helpful to present all options
prior to the VCM and then identify preferred option(s)
for further consideration. However, patients require
sufficient knowledge of options to realize that certain
attributes or values are relevant [15].
Assessing capacity of the patient for a VCM
More research is needed to identify which types of
patients are able to benefit from which VCMs, how cog-
nitive deficits (e.g., age-related loss of executive func-
tioning) and/or mental illness or other conditions might
adversely affect the use of VCMs, and which types of
VCMs are best suited for these populations.
Empirical evidence base
Our systematic review found that the research questions
and outcome variables being tested vary widely across
studies. It may be helpful for studies to use at least a sub-
set of standard measures so that study results can be more
easily compared. We found that reporting of results is
quite consistent, with the exception of the development
process for VCMs. We recommend succinct reporting of:
1) the rationale for the design used (theory, previous
designs, literature), 2) who was involved in its develop-
ment (e.g., clinical experts, patients, advisory panel, etc.),
and 3) how was stakeholder input incorporated (focus
groups, individual interview, pilot testing, etc.). We also
refer authors of reports of VCMs to Witteman et al.’s
systematic review, where we report a more thorough set
of categories for reporting.
Conclusion
As described above, the theoretical and empirical basis
for values clarifications research has changed signifi-
cantly since the International Patient Decision Aid Stan-
dards (IPDAS) Collaboration’s 2005 review of values
clarification methods in decision aids. Yet, there are still
many areas that need considerable research before we
can make strong conclusions about the use of VCMs in
patient decision aids.
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